M

Microba Life Sciences Ltd
ASX:MAP

Watchlist Manager
Microba Life Sciences Ltd
ASX:MAP
Watchlist
Price: 0.086 AUD 1.18% Market Closed
Market Cap: AU$52.4m

Microba Life Sciences Ltd
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Microba Life Sciences Ltd
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
M
Microba Life Sciences Ltd
ASX:MAP
EPS (Diluted)
AU$0
CAGR 3-Years
16%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Sonic Healthcare Ltd
ASX:SHL
EPS (Diluted)
AU$1
CAGR 3-Years
-20%
CAGR 5-Years
-11%
CAGR 10-Years
2%
Integral Diagnostics Ltd
ASX:IDX
EPS (Diluted)
AU$0
CAGR 3-Years
-34%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
Australian Clinical Labs Ltd
ASX:ACL
EPS (Diluted)
AU$0
CAGR 3-Years
-42%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Apiam Animal Health Ltd
ASX:AHX
EPS (Diluted)
AU$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Healius Ltd
ASX:HLS
EPS (Diluted)
AU$0
CAGR 3-Years
N/A
CAGR 5-Years
-16%
CAGR 10-Years
N/A
No Stocks Found

Microba Life Sciences Ltd
Glance View

Market Cap
52.4m AUD
Industry
Health Care

Microba Life Sciences is a precision microbiome science company powering medical innovation to transform human health. The company is headquartered in Brisbane, Queensland. The company went IPO on 2022-04-05. The firm specializes in the analysis of gut microbiome and promotes development in pathology services, therapeutics and diagnostics based on the microbiome. The firm's flagship product is the Microba Insight, a sampling kit that allows the public to analyze personal gut microbiome. Its discovery platform uses human data and informatic approaches to connect microbial genotype to human phenotype. The company also offers support solutions to researchers.

MAP Intrinsic Value
HIDDEN
Show

See Also

What is Microba Life Sciences Ltd's EPS (Diluted)?
EPS (Diluted)
-0 AUD

Based on the financial report for Jun 30, 2025, Microba Life Sciences Ltd's EPS (Diluted) amounts to -0 AUD.

What is Microba Life Sciences Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-8%

Over the last year, the EPS (Diluted) growth was 40%. The average annual EPS (Diluted) growth rates for Microba Life Sciences Ltd have been 16% over the past three years , -8% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett